These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1322381)

  • 21. Identification of H-2Kb-, Db- and Dd-binding peptides derived from amino acid sequences of polyoma virus T antigens.
    Reinholdsson-Ljunggren G; Franksson L; Dalianis T; Ljunggren HG
    Int J Cancer; 1993 Jul; 54(6):992-5. PubMed ID: 8335406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased.
    Heidari S; Berke Z; Berglöf A; Woldegiorgis A; Smith CI; Dalianis T
    In Vivo; 1999; 13(6):439-44. PubMed ID: 10757034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expression.
    Soares LR; Sercarz EE; Miller A
    Int Immunol; 1994 May; 6(5):785-94. PubMed ID: 7521670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.
    Ramqvist T; Dalianis T; Reinholdsson G; Klein G; Szigeti R
    Cancer Res; 1986 Oct; 46(10):5045-8. PubMed ID: 3019520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polyomavirus tumor-specific transplantation antigen (TSTA) epitope is situated within the N-terminal amino acid sequence common to middle and small T-antigens.
    Reinholdsson G; Ramqvist T; Brandberg J; Dalianis T
    Virology; 1988 Oct; 166(2):616-9. PubMed ID: 2459846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of various tumor-specific antigens in polyoma virus-induced tumors.
    Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB
    Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.
    Lukacher AE; Ma Y; Carroll JP; Abromson-Leeman SR; Laning JC; Dorf ME; Benjamin TL
    J Exp Med; 1995 May; 181(5):1683-92. PubMed ID: 7722447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyoma antigen driven T lymphocytes with antitumor and DTH activity in CBA mice.
    Ochałek T; Cadel Z
    Neoplasma; 1988; 35(3):271-8. PubMed ID: 3261395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies specific for the polyoma virus middle-size tumor antigen.
    Walter G; Hutchinson MA; Hunter T; Eckhart W
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4882-6. PubMed ID: 6272281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: implications for autoimmunity and infection.
    Moudgil KD; Wang J; Yeung VP; Sercarz EE
    J Immunol; 1998 Dec; 161(11):6046-53. PubMed ID: 9834087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of Peptide-25 of Ag85B in Th1 development: role of IFN-gamma.
    Kariyone A; Tamura T; Kano H; Iwakura Y; Takeda K; Akira S; Takatsu K
    Int Immunol; 2003 Oct; 15(10):1183-94. PubMed ID: 13679388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?
    Dalianis T; Ramqvist T; Klein G
    Int J Cancer; 1984 Sep; 34(3):403-6. PubMed ID: 6090322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors.
    Toes RE; Blom RJ; Offringa R; Kast WM; Melief CJ
    J Immunol; 1996 May; 156(10):3911-8. PubMed ID: 8621930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.
    Greer JM; Sobel RA; Sette A; Southwood S; Lees MB; Kuchroo VK
    J Immunol; 1996 Jan; 156(1):371-9. PubMed ID: 8598487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.
    Kemball CC; Lee ED; Vezys V; Pearson TC; Larsen CP; Lukacher AE
    J Immunol; 2005 Jun; 174(12):7950-60. PubMed ID: 15944301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro generation of therapeutic noncytolytic T-cells by soluble polyoma TAA and Il-2.
    Ochalek T; von Kleist S
    Anticancer Res; 1993; 13(4):1171-7. PubMed ID: 8394674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.